Funding Rounds
EsoBiotec

EsoBiotec Series A (2023, $2M)

EsoBiotec

Vivo engineered cell therapies for cancer treatment.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $2.16M

Raised Date: 2023-12-01

Investors